GSK-115992

Study Sponsor: GSK

Study Title

Two-dose primary vaccination with either GSK Biologicals' 10-valent pneumococcal vaccine (Synflorix™) or Pfizer’s Prevenar 13™ or both vaccines followed by a booster dose of Synflorix™

Medicine or Vaccine (generic name)

10-valent pneumococcal polysaccharide and non-typeable Haemophilus influenzae protein D conjugate vaccine

Sponsor Identification Number

115992

Trial Registry Identification Number(#'s)

NCT01641133 2013-003479-36

Medical Condition

Infections, Streptococcal

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=115992

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT01641133

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2013-003479-36

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

January 2021